PARP1 and neoplasm: In addition to inherent genetics, tumor cells can be preferentially sensitized to radiotherapy through various mechanisms, including proliferation-dependent radiosensitization, targeting of the endothelium and tumor vasculature, and increased sensitivity to PARP inhibitors in repair-deficient hypoxic cells [151].